{"id":{"repo_id":"glasgow","oai_identifier":"oai:theses.gla.ac.uk:5553"},"canonical_url":"https://search.ndltd.org/etd/glasgow/oai:theses.gla.ac.uk:5553","repository":{"repo_id":"glasgow","name":"University of Glasgow","base_url":"https://theses.gla.ac.uk/cgi/oai2"},"display":{"title":"Identification and characterization of novel histone modifications during cellular senescence","abstract":"Cellular senescence is a stable cell cycle arrest and can be triggered by various signals including telomere shortening, oncogenic activation and other stress activators. Senescence is accompanied by changes in the cellular organization, gene expression and induction of the secretome. It is established and maintained by at least two major tumor suppressor pathways, the p53-p21 and p16-pRB pathways. Senescence is now recognized as a potent barrier to tumor progression and is directly and indirectly linked to a large array of age-related pathologies. However the precise molecular mechanisms of senescence, particularly how cells are driven into irreversible proliferation arrest, in not fully understood. It is well known that widespread changes in the chromatin structure of senescence contribute to the senescent phenotype. In line with this, the primary objective of this project is to understand how senescence is regulated by its chromatin structure. I have focussed on the identification and characterization of novel histone modifications that occur during senescence. Large-scale profiling of histone modifications was performed in replicatively senescent cells in comparison to proliferating cells. Candidate histone modifications were identified that alter during senescence from the screen. To our knowledge, this is the first study to have implied a novel role for these histone modifications during senescence. Also a third histone modification, H4K16ac, was chosen for study based on ChIP-seq observations made in the lab. The mark has also been extensively linked to cancer and aging. All together, work from this project imparts new knowledge on how certain novel histone modifications might regulate senescence via critical modulation of its chromatin structure and how they may impinge on senescence-associated effects such as ageing and cancer.","abstract_html":"Cellular senescence is a stable cell cycle arrest and can be triggered by various signals including telomere shortening, oncogenic activation and other stress activators. Senescence is accompanied by changes in the cellular organization, gene expression and induction of the secretome. It is established and maintained by at least two major tumor suppressor pathways, the p53-p21 and p16-pRB pathways. Senescence is now recognized as a potent barrier to tumor progression and is directly and indirectly linked to a large array of age-related pathologies. However the precise molecular mechanisms of senescence, particularly how cells are driven into irreversible proliferation arrest, in not fully understood. It is well known that widespread changes in the chromatin structure of senescence contribute to the senescent phenotype. In line with this, the primary objective of this project is to understand how senescence is regulated by its chromatin structure. I have focussed on the identification and characterization of novel histone modifications that occur during senescence. Large-scale profiling of histone modifications was performed in replicatively senescent cells in comparison to proliferating cells. Candidate histone modifications were identified that alter during senescence from the screen. To our knowledge, this is the first study to have implied a novel role for these histone modifications during senescence. Also a third histone modification, H4K16ac, was chosen for study based on ChIP-seq observations made in the lab. The mark has also been extensively linked to cancer and aging. All together, work from this project imparts new knowledge on how certain novel histone modifications might regulate senescence via critical modulation of its chromatin structure and how they may impinge on senescence-associated effects such as ageing and cancer.","abstract_has_math":false,"creators":["Manoharan, Indrani"],"institution":"University of Glasgow","degree_name":null,"degree_level":"PhD","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2014,"date_issued":"2014","date_published":"2014","updated_at":"2026-11-19T08:23:46Z","subjects":["QH345 Biochemistry"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":null,"outbound_label":null,"outbound_source":null,"record_url":null,"record_label":null,"record_kind":null,"record_source":null,"download_url":"https://theses.gla.ac.uk/5553/1/2014ManoharanPhD.pdf","download_label":"Download PDF","download_source":"dc:identifier.uri","access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://theses.gla.ac.uk/cgi/oai2?verb=GetRecord&metadataPrefix=uketd_dc&identifier=oai%3Atheses.gla.ac.uk%3A5553","prefix":"uketd_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Manoharan, Indrani"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2014"]},{"key":"dc:date.issued","label":"Date","values":["2014"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Glasgow"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://theses.gla.ac.uk/5553/"]},{"key":"dc:relation.isreferencedby.uri","label":"Dc Relation Isreferencedby URI","values":["https://gla.on.worldcat.org/oclc/900445176"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["QH345 Biochemistry"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["en"]},{"key":"dc:rights.embargoreason","label":"Dc Rights Embargoreason","values":["Embargo expired 30 September 2017, e-version uploaded 3-Oct-17 MC. Thesis contains unpublished data."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://theses.gla.ac.uk/5553/1/2014ManoharanPhD.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Cellular senescence is a stable cell cycle arrest and can be triggered by various signals including telomere shortening, oncogenic activation and other stress activators. Senescence is accompanied by changes in the cellular organization, gene expression and induction of the secretome. It is established and maintained by at least two major tumor suppressor pathways, the p53-p21 and p16-pRB pathways. Senescence is now recognized as a potent barrier to tumor progression and is directly and indirectly linked to a large array of age-related pathologies. However the precise molecular mechanisms of senescence, particularly how cells are driven into irreversible proliferation arrest, in not fully understood. It is well known that widespread changes in the chromatin structure of senescence contribute to the senescent phenotype. In line with this, the primary objective of this project is to understand how senescence is regulated by its chromatin structure. I have focussed on the identification and characterization of novel histone modifications that occur during senescence. Large-scale profiling of histone modifications was performed in replicatively senescent cells in comparison to proliferating cells. Candidate histone modifications were identified that alter during senescence from the screen. To our knowledge, this is the first study to have implied a novel role for these histone modifications during senescence. Also a third histone modification, H4K16ac, was chosen for study based on ChIP-seq observations made in the lab. The mark has also been extensively linked to cancer and aging. All together, work from this project imparts new knowledge on how certain novel histone modifications might regulate senescence via critical modulation of its chromatin structure and how they may impinge on senescence-associated effects such as ageing and cancer."]},{"key":"dc:format","label":"Dc Format","values":["pdf"]},{"key":"dcterms:accessrights","label":"Dcterms Accessrights","values":["public"]},{"key":"dc:title","label":"Title","values":["Identification and characterization of novel histone modifications during cellular senescence"]}]}],"canonical_facts":{"dc:creator":["Manoharan, Indrani"],"dc:date":["2014"],"dc:date.issued":["2014"],"dc:description.abstract":["Cellular senescence is a stable cell cycle arrest and can be triggered by various signals including telomere shortening, oncogenic activation and other stress activators. Senescence is accompanied by changes in the cellular organization, gene expression and induction of the secretome. It is established and maintained by at least two major tumor suppressor pathways, the p53-p21 and p16-pRB pathways. Senescence is now recognized as a potent barrier to tumor progression and is directly and indirectly linked to a large array of age-related pathologies. However the precise molecular mechanisms of senescence, particularly how cells are driven into irreversible proliferation arrest, in not fully understood. It is well known that widespread changes in the chromatin structure of senescence contribute to the senescent phenotype. In line with this, the primary objective of this project is to understand how senescence is regulated by its chromatin structure. I have focussed on the identification and characterization of novel histone modifications that occur during senescence. Large-scale profiling of histone modifications was performed in replicatively senescent cells in comparison to proliferating cells. Candidate histone modifications were identified that alter during senescence from the screen. To our knowledge, this is the first study to have implied a novel role for these histone modifications during senescence. Also a third histone modification, H4K16ac, was chosen for study based on ChIP-seq observations made in the lab. The mark has also been extensively linked to cancer and aging. All together, work from this project imparts new knowledge on how certain novel histone modifications might regulate senescence via critical modulation of its chromatin structure and how they may impinge on senescence-associated effects such as ageing and cancer."],"dc:format":["pdf"],"dc:identifier.uri":["https://theses.gla.ac.uk/5553/1/2014ManoharanPhD.pdf"],"dc:language":["en"],"dc:publisher.institution":["University of Glasgow"],"dc:relation.isreferencedby":["https://theses.gla.ac.uk/5553/"],"dc:relation.isreferencedby.uri":["https://gla.on.worldcat.org/oclc/900445176"],"dc:rights.embargoreason":["Embargo expired 30 September 2017, e-version uploaded 3-Oct-17 MC. Thesis contains unpublished data."],"dc:subject":["QH345 Biochemistry"],"dcterms:accessrights":["public"],"dc:title":["Identification and characterization of novel histone modifications during cellular senescence"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["PhD"]},"updated_at":"2026-11-19T08:23:46Z"}